John Carreyrou is a two-time Pulitzer Prize–winning investigative reporter at the Wall Street Journal. In his New York Times bestselling book Bad Blood, John Carreyrou shares the full inside story of the breathtaking rise and shocking collapse of the one-time multi-billion-dollar Silicon Valley company that rose to fame with the promise of blood-testing technology that never existed.
In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: The technology didn’t work. Carreyrou was the first to break the scandal surrounding the failed biomedical startup Theranos and the disturbing lies of its wunderkind founder, Elizabeth Holmes, in his reporting for The Wall Street Journal. For his extensive coverage of Theranos, Carreyrou was awarded the George Polk Award for Financial Reporting, the Gerald Loeb Award for Distinguished Business and Financial Journalism in the category of beat reporting, and the Barlett & Steele Silver Award for Investigative Business Journalism. Bad Blood was named the Financial Times & McKinsey Business Book of the Year. Carreyrou lives in Brooklyn, New York, with his wife and three children.
Part of the BIG IDEA project Marketplaces: From Open Air to Online.
